Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Piper vs Rebody Health

Piper
Graded #34

Higher grade

vs+14.200000000000003
Rebody Health
Graded #159

Lower grade

The verdict

Piper takes it — 81.9/100 to 67.7/100.

Piper grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mid-value both-molecule pricing ($135/$199), nationwide, though not verified.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePiper +40
86
46
Dose & formulationRebody Health +8
80
88
Clinical oversightRebody Health +2
79
81
Labs & monitoringPiper +25
78
53
FulfillmentPiper +2
86
84
Contract termsPiper +27
82
55
Piper · left barRebody Health · right bar

The numbers

MetricPiperRebody Health
WeighScore81.9/10067.7/100
GradeB−C
Scorecard rank#34#159
Semaglutide$135/mo$200/mo (starting dose, compounded)
Tirzepatide$199/mo$250/mo (starting dose, compounded)
CoverageAll 50 states47 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Piper

Graded #34 · B−

Strengths

  • $135 sema / $199 tirz
  • All 50 states
  • Both molecules

Where it loses points

  • Not LegitScript-verified
  • Injection-only
  • Monitoring detail limited
Rebody Health

Graded #159 · C

Strengths

  • Publishes transparent, dose-based pricing up front on a public pricing page, so you can see costs without signing up
  • Offers compounded semaglutide and tirzepatide as both weekly injections and daily oral 'melt' tablets
  • Also carries brand-name Wegovy and Zepbound for patients who want FDA-approved products
  • Clear plan-term vs dose-tier structure; the refill price is shown before each shipment, plus $50 off the first month
  • Names its operating company (Compound Technologies Inc.) and references LegitScript approval

Where it loses points

  • Individual compounding pharmacies are not named on the marketing site
  • Not available in Massachusetts, Rhode Island, or Vermont
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
  • Dose-scaled pricing means the monthly cost can rise as your prescribed dose increases

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard